Volume | 1,406,780 |
|
|||||
News | - | ||||||
Day High | 41.68 | Low High |
|||||
Day Low | 41.06 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Qiagen NV | QGEN | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
41.10 | 41.06 | 41.68 | 41.65 | 41.08 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
13,887 | 1,406,780 | US$ 41.50 | US$ 58,374,949 | - | 35.8135 - 49.1739 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 122,232 | US$ 41.65 | USD |
Qiagen NV Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.5B | 228.20M | - | 1.97B | 341.3M | 1.50 | 27.85 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Qiagen NV News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical QGEN Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 39.64 | 41.94 | 39.64 | 41.10 | 1,059,462 | 2.01 | 5.07% |
1 Month | 43.15 | 43.42 | 39.03 | 40.99 | 903,991 | -1.50 | -3.48% |
3 Months | 43.54 | 45.38 | 39.03 | 42.86 | 1,011,769 | -1.89 | -4.34% |
6 Months | 37.9784 | 47.2925 | 35.8135 | 42.93 | 1,189,436 | 3.67 | 9.67% |
1 Year | 45.5555 | 49.1739 | 35.8135 | 43.96 | 1,167,802 | -3.91 | -8.57% |
3 Years | 53.2047 | 59.7922 | 35.8135 | 47.39 | 941,668 | -11.55 | -21.72% |
5 Years | 39.8855 | 60.8231 | 25.5663 | 44.62 | 1,165,912 | 1.76 | 4.42% |
Qiagen NV Description
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%). |